Accelerated Early Phase Decision-Making – Insider Insights to Speed Development
Access insider insights from combined perspectives of clinical pharmacology, global regulatory considerations, and private equity investors on accelerating early development timelines to go/no go decisions and early proof of concept, without shortcuts. Parexel’s early phase team and EQT LifeSciences share best practices for combining sequential early phase studies into a single protocol.
Related Insights
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Article
Maximize the efficiency of regulatory operations with five key competencies
Jul 23, 2021
Blog
Focusing on value drivers to reduce risk in early-stage drug development
Jan 6, 2025
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Podcast
Pharma Talk Radio: Building a Successful Relationship with your Development Partner
Oct 5, 2021
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Article
Near-term strategies for biotech drug developers facing shifting healthcare dynamics
Feb 14, 2024
Video
Overcoming asset transfer challenges during a merger and acquisition (M&A)
Oct 20, 2021
Blog
3 steps for making your CRO relationships more successful
Jul 29, 2021
Related Insights
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Article
Maximize the efficiency of regulatory operations with five key competencies
Jul 23, 2021
Blog
Focusing on value drivers to reduce risk in early-stage drug development
Jan 6, 2025
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Podcast
Pharma Talk Radio: Building a Successful Relationship with your Development Partner
Oct 5, 2021
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Article
Near-term strategies for biotech drug developers facing shifting healthcare dynamics
Feb 14, 2024
Video
Overcoming asset transfer challenges during a merger and acquisition (M&A)
Oct 20, 2021
Blog
3 steps for making your CRO relationships more successful
Jul 29, 2021